The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma

Resistance to the proteasome inhibitor bortezomib (BTZ) represents a major obstacle in the treatment of multiple myeloma (MM). The contribution of lipid metabolism in the resistance of MM cells to BTZ is mostly unknown. Here we report that levels of fatty acid elongase 6 (ELOVL6) were lower in MM ce...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Adv
Main Authors: Lipchick, Brittany C., Utley, Adam, Han, Zhannan, Moparthy, Sudha, Yun, Dong Hyun, Bianchi-Smiraglia, Anna, Wolff, David W., Fink, Emily, Liu, Liang, Furdui, Cristina M., Lee, Jingyun, Lee, Kelvin P., Nikiforov, Mikhail A.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2021
Fag:
Myeloid Neoplasia
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045499/
https://ncbi.nlm.nih.gov/pubmed/33821992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002578
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker